GGrantIndex
Sort

38,696 grants matching als

Laboratory and Clinical studies on T-cells recognizing NSCLC

$304,871
James C Yang · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

SIRTUIN AGONISTS AS PAN INFLUENZA ANTIVIRALS

$304,858
Stacy Remiszewski · Evrys Bio, Llc · R44 · FY2016 · AI

Novel CatSper3 and CatSper4 Ion Channel Genes in Sperm

$304,831
David E. Clapham · Boston Children'S Hospital · R01 · FY2008 · HD

Cell Assemblies Pattern Completion and the Aging Brain

$304,793
Carol A. Barnes · University Of Arizona · R37 · FY2010 · AG

Determinants of Response to Type 1 Insulin-Like Growth Factor Inhibition in Prost

$304,747
Stephen R Plymate · University Of Washington · P01 · FY2011 · CA

Molecular Genetics of Manganese Induced Dopamine Neuron Toxicity

$304,742
Richard M Nass · Indiana University Indianapolis · R01 · FY2008 · ES

Mechanism of Action of Differentiation Agents

$304,695
Michael G Brattain · University Of Nebraska Medical Center · R01 · FY2013 · CA

Molecular control of neural cell fate determination

$304,690
California Institute Of Technology · R01 · FY2004 · NS

Molecular control of neural cell fate determination

$304,690
California Institute Of Technology · R01 · FY2002 · NS

Molecular control of neural cell fate determination

$304,690
California Institute Of Technology · R01 · FY2001 · NS

Molecular control of neural cell fate determination

$304,690
California Institute Of Technology · R01 · FY2003 · NS

The Process of Group Therapy for Cocaine Dependence

$304,636
Paul F Crits-Christoph · University Of Pennsylvania · R01 · FY2007 · DA

Membrane Sealing:Biopolymers for Tissue Electroporation

$304,626
University Of Chicago · R01 · FY2005 · GM

Membrane Sealing:Biopolymers for Tissue Electroporation

$304,626
University Of Chicago · R01 · FY2004 · GM

Role of Prox1 in Murine Pancreas Development

$304,584
Beatriz Sosa-Pineda · St. Jude Children'S Research Hospital · R01 · FY2009 · DK

Novel RNAi therapy for ALS and other Neurodegenerative Disorders

$304,559
Lyn Libertine · Rxi Pharmaceuticals Corporation · R43 · FY2011 · NS

Project 2: The impact of TRiC reagents on mHTT-induced neuronal degeneration in vitro

$304,528
William C Mobley · University Of California-Irvine · P01 · FY2018 · NS

Using RNA signatures for therapy development in neurodegeneration due to C9orf72 expansions

$304,500
Clotilde Lagier-Tourenne · Massachusetts General Hospital · R01 · FY2018 · NS

Using RNA signatures for therapy development in neurodegeneration due to C9orf72 expansions

$304,500
Clotilde Lagier-Tourenne · Massachusetts General Hospital · R01 · FY2017 · NS

Using RNA signatures for therapy development in neurodegeneration due to C9orf72 expansions

$304,500
Clotilde Lagier-Tourenne · Massachusetts General Hospital · R01 · FY2016 · NS

BCI2000: SOFTWARE FOR BRAIN-COMPUTER INTERFACE RESEARCH

$304,496
Gerwin Schalk · Wadsworth Center · R01 · FY2007 · EB

STRUCTURE &ASSEMBLY OF COLLAGEN MOLECULES &FIBRILS

$304,480
Northwestern University · R01 · FY2003 · AR

Mechanisms of Effective Family Change in High Risk Youth

$304,413
James F Alexander · University Of Utah · R01 · FY2006 · DA

Membrane Potential and cAMP Crosstalk in Sperm Capacitation

$304,410
Pablo Eduardo Visconti · University Of Massachusetts Amherst · R01 · FY2007 · HD

Information processing in sensory systems

$304,400
S. Murray Sherman · University Of Chicago · R01 · FY2011 · DC